Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
14.97%
operating margin TTM
16.16%
revenue TTM
657.24 Million
revenue per share TTM
3.45$
valuation ratios | |
|---|---|
| pe ratio | 31.55 |
| peg ratio | 1.00 |
| price to book ratio | 2.38 |
| price to sales ratio | 4.73 |
| enterprise value multiple | 21.24 |
| price fair value | 2.38 |
profitability ratios | |
|---|---|
| gross profit margin | 78.64% |
| operating profit margin | 16.16% |
| pretax profit margin | 19.01% |
| net profit margin | 14.97% |
| return on assets | 6.11% |
| return on equity | 7.97% |
| return on capital employed | 7.22% |
liquidity ratio | |
|---|---|
| current ratio | 5.33 |
| quick ratio | 3.29 |
| cash ratio | 1.55 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 738.99 |
| operating cycle | 823.56 |
| days of payables outstanding | 141.13 |
| cash conversion cycle | 682.44 |
| receivables turnover | 4.32 |
| payables turnover | 2.59 |
| inventory turnover | 0.49 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.09 |
| debt equity ratio | 0.11 |
| long term debt to capitalization | 0.10 |
| total debt to capitalization | 0.10 |
| interest coverage | 37.33 |
| cash flow to debt ratio | 0.95 |
cash flow ratios | |
|---|---|
| free cash flow per share | 2.49 |
| cash per share | 5.97 |
| operating cash flow per share | 3.00 |
| free cash flow operating cash flow ratio | 0.83 |
| cash flow coverage ratios | 0.95 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 5.88 |
Frequently Asked Questions
When was the last time BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reported earnings?
BioMarin Pharmaceutical Inc. (BMRN) published its most recent earnings results on 31-10-2024.
What is BioMarin Pharmaceutical Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)'s trailing twelve months ROE is 7.97%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BioMarin Pharmaceutical Inc. (BMRN) currently has a ROA of 6.11%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BMRN's net profit margin stand at?
BMRN reported a profit margin of 14.97% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BMRN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.33 in the most recent quarter. The quick ratio stood at 3.29, with a Debt/Eq ratio of 0.11.